Mankind Pharma Limited (NSE:MANKIND)

India flag India · Delayed Price · Currency is INR
2,333.40
+29.90 (1.30%)
Jun 27, 2025, 3:30 PM IST
9.06%
Market Cap 973.34B
Revenue (ttm) 122.07B
Net Income (ttm) 19.91B
Shares Out 412.73M
EPS (ttm) 49.20
PE Ratio 48.04
Forward PE 46.42
Dividend n/a
Ex-Dividend Date n/a
Volume 235,920
Average Volume 378,868
Open 2,323.40
Previous Close 2,303.50
Day's Range 2,309.30 - 2,360.90
52-Week Range 1,901.05 - 3,054.80
Beta 0.49
RSI 42.68
Earnings Date Jul 31, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m... [Read more]

Sector Healthcare
Founded 1991
Employees 19,540
Stock Exchange National Stock Exchange of India
Ticker Symbol MANKIND
Full Company Profile

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.12% compared to the previous year's 103.35 billion. Earnings were 19.91 billion, an increase of 4.08%.

Financial Statements

News

There is no news available yet.